HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seong Hoon Yoon Selected Research

Tyrosine (L-Tyrosine)

1/2021Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seong Hoon Yoon Research Topics

Disease

16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2018
10Lung Neoplasms (Lung Cancer)
05/2024 - 01/2016
9Neoplasms (Cancer)
01/2023 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2024 - 06/2023
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2023 - 06/2016
2Hemorrhage
07/2023 - 05/2017
2Adenocarcinoma of Lung
01/2021 - 02/2019
2Infections
07/2018 - 06/2016
1Tuberculosis (Tuberculoses)
11/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2023
1Carcinoma (Carcinomatosis)
10/2022
1Brain Neoplasms (Brain Tumor)
12/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
12/2021
1Adenocarcinoma
02/2019
1Catheter-Related Infections
07/2018
1Carcinogenesis
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Lung Diseases (Lung Disease)
12/2017
1Common Cold
12/2017
1Critical Illness (Critically Ill)
05/2017
1Ischemia
08/2016
1Sepsis (Septicemia)
06/2016
1Lewis Lung Carcinoma
01/2016
1Pleural Effusion (Pleural Effusions)
07/2015
1Pleural Tuberculosis
07/2015

Drug/Important Bio-Agent (IBA)

8ErbB Receptors (EGF Receptor)IBA
11/2023 - 11/2020
7AfatinibIBA
11/2023 - 12/2020
4Immune Checkpoint InhibitorsIBA
05/2024 - 01/2021
4Tyrosine Kinase InhibitorsIBA
03/2022 - 12/2020
3Biomarkers (Surrogate Marker)IBA
01/2023 - 02/2019
3Cisplatin (Platino)FDA LinkGeneric
10/2022 - 01/2016
3Granzymes (Granzyme)IBA
06/2022 - 02/2022
2CrizotinibIBA
01/2024 - 01/2024
2atezolizumabIBA
10/2023 - 01/2023
2osimertinibIBA
10/2023 - 01/2021
1Anaplastic Lymphoma KinaseIBA
01/2024
1CaspasesIBA
10/2022
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
10/2022
1protein kinase modulatorIBA
10/2022
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
10/2022
1A-Form DNA (A-DNA)IBA
12/2021
1Therapeutic UsesIBA
12/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1LigandsIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
11/2020
1Messenger RNA (mRNA)IBA
11/2020
1Protein Kinases (Protein Kinase)IBA
02/2019
1Carbapenems (Carbapenem Antibiotics)IBA
07/2018
1Phosphotransferases (Kinase)IBA
01/2018
1p21-Activated KinasesIBA
01/2018
1Adenosine Monophosphate (AMP)IBA
01/2018
1AnticoagulantsIBA
05/2017
1Cyclin D1IBA
01/2016
1Indicators and Reagents (Reagents)IBA
07/2015

Therapy/Procedure

9Therapeutics
10/2023 - 06/2016
7Extracorporeal Membrane Oxygenation
10/2023 - 06/2016
3Immunotherapy
05/2024 - 02/2022
3Drug Therapy (Chemotherapy)
10/2023 - 01/2016
2Catheters
07/2018 - 06/2016
1Time-to-Treatment
01/2022
1Drug Tapering
12/2021
1Adjuvant Chemotherapy
02/2019
1Complementary Therapies (Alternative Medicine)
12/2017
1Lung Transplantation
12/2017
1Surgical Hemostasis
05/2017
1Tracheostomy
05/2017
1Cannula
08/2016